Explore 3 Stock Ideas & Industry Insights Download Free Report

News

MasterBrand (NYSE:MBC) Advances 3.43% as Housing Bill Drives Cabinet Volume Outlook Higher

• MasterBrand is up 3.43% intraday at $9.66 with above-average volume, suggesting institutional participation in the housing sector catalyst.

Vinay Lochav | 25 June 2026

Mohawk Industries (NYSE:MHK) Advances 2.07% as Housing Bill Improves Flooring Demand Across Both Channels

• Mohawk Industries is up 2.07% intraday at $121.56, holding gains steadily in line with building-products peers responding to the same Congressional housing catalyst.

Vinay Lochav | 25 June 2026

Primoris Services (NYSE:PRIM) Rises 2.97% to $95.44 as Goldman Sachs Upgrade Catalyses Relief Bounce After 50% Collapse

• Primoris Services is up 2.97% intraday at $95.44 from a prior close of approximately $93.37, with the Goldman Sachs upgrade to Neutral as the direct catalyst for today's relief bounce.

Vinay Lochav | 25 June 2026

Domo (NASDAQ:DOMO) Slips 3.09% as Enterprise Software Rotation Weighs on Small-Cap Analytics Platform

• Domo is trading at $2.67, down 3.09% intraday, on light volume without any earnings release or material company news.

Vinay Lochav | 25 June 2026

Fortune Brands Innovations (NYSE:FBIN) Advances 2.88% as Housing Bill Lifts Building Products Complex

• Fortune Brands Innovations is trading at $45.94, up 2.88% intraday, driven by Congressional passage of a bipartisan housing supply bill that shifted the new-construction demand outlook.

Vinay Lochav | 25 June 2026

Gibraltar Industries (NASDAQ:ROCK) Gains 2.65% on Dual Housing and Renewable Energy Sector Tailwinds

• Gibraltar Industries is up 2.65% intraday at $44.34 with modestly above-average volume, with the gain holding steadily through the session.

Vinay Lochav | 25 June 2026

HNI Corporation (NYSE:HNI) Advances 2.87% as Housing Supply Bill Directly Lifts Hearth Products Outlook

• HNI Corporation is up 2.87% intraday at $38.40, with gains holding steadily through the afternoon, suggesting genuine institutional participation.

Vinay Lochav | 25 June 2026

Nuvectis Pharma (NASDAQ:NVCT) Eases 2.08% in Routine Profit-Taking After Active Recent Period

• Nuvectis Pharma is down 2.08% intraday at $23.97 in orderly selling without a panicked character, consistent with routine profit-taking after an active recent period.

Vinay Lochav | 25 June 2026

Palvella Therapeutics (NASDAQ:PVLA) Advances 2.80% as Rare Disease Biotech Sentiment Lifts QTORIN Programme

• Palvella Therapeutics is up 2.80% intraday at $133.47, with thin trading and the gain reflecting passive sector-level accumulation rather than directional news-driven buying.

Vinay Lochav | 25 June 2026

Personalis (NASDAQ:PSNL) Surges 9.33% as Bio-Techne M&A Re-Rates Whole-Genome Cancer Sequencing Platforms

• Personalis is up 9.33% intraday at $12.42 with above-average volume, with the bulk of the gain occurring at the open and then holding, consistent with short-covering followed by lighter sustained buying.

Vinay Lochav | 25 June 2026
Support

Hi! How can we help you today?

Loading…